{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:46:52Z","timestamp":1781059612091,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The National Key Technologies R&D Program for the 13th Five\u2010year Plan","award":["2017ZX10202101\u2010001"],"award-info":[{"award-number":["2017ZX10202101\u2010001"]}]},{"name":"The Key Clinical Specialties Program of Beijing and China and National High-Level Hospital Clinical Research Funding","award":["2022-PUMCH-D-008"],"award-info":[{"award-number":["2022-PUMCH-D-008"]}]},{"name":"The Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2021-I2M-1-037"],"award-info":[{"award-number":["2021-I2M-1-037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05681-y","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T13:01:55Z","timestamp":1728046915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus \/Hepatitis B Virus coinfection on treatment"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaodi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"5681_CR1","unstructured":"World Health Organization: Hepatitis B. Updated 24 June 2022. Accessed 01. May 2023, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"issue":"4","key":"5681_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","volume":"20","author":"SG Lim","year":"2023","unstructured":"Lim SG, Baumert TF, Boni C, et al. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat Rev Gastroenterol Hepatol Apr. 2023;20(4):238\u201353. https:\/\/doi.org\/10.1038\/s41575-022-00724-5.","journal-title":"Nat Rev Gastroenterol Hepatol Apr"},{"key":"5681_CR3","doi-asserted-by":"publisher","unstructured":"Cornberg M, Lok AS, Terrault NA, Zoulim F, Faculty E-AHTEC. Mar. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference(double dagger). J Hepatol. 2020;72(3):539\u2013557. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.003","DOI":"10.1016\/j.jhep.2019.11.003"},{"issue":"11","key":"5681_CR4","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/infdis\/jiab241","volume":"1","author":"YC Hsu","year":"2021","unstructured":"Hsu YC, Yeh ML, Wong GL, et al. Incidences and determinants of functional cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. J Infect Dis Dec. 2021;1(11):1890\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiab241.","journal-title":"J Infect Dis Dec"},{"issue":"6","key":"5681_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s12072-022-10411-x","volume":"16","author":"YC Hsu","year":"2022","unstructured":"Hsu YC, Jun DW, Peng CY, et al. Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort. Hepatol Int Dec. 2022;16(6):1297\u2013307. https:\/\/doi.org\/10.1007\/s12072-022-10411-x.","journal-title":"Hepatol Int Dec"},{"issue":"1","key":"5681_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40249-021-00876-7","volume":"1","author":"H Ahmadi Gharaei","year":"2021","unstructured":"Ahmadi Gharaei H, Fararouei M, Mirzazadeh A, et al. The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis. Infect Dis Poverty Jul. 2021;1(1):93. https:\/\/doi.org\/10.1186\/s40249-021-00876-7.","journal-title":"Infect Dis Poverty Jul"},{"issue":"12","key":"5681_CR7","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1111\/liv.14684","volume":"40","author":"K van Bremen","year":"2020","unstructured":"van Bremen K, Hoffmann C, Mauss S, et al. Obstacles to HBV functional cure: late presentation in HIV and its impact on HBV seroconversion in HIV\/HBV coinfection. Liver Int Dec. 2020;40(12):2978\u201381. https:\/\/doi.org\/10.1111\/liv.14684.","journal-title":"Liver Int Dec"},{"issue":"12","key":"5681_CR8","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/infdis\/jiaa662","volume":"15","author":"S Yoshikawa","year":"2021","unstructured":"Yoshikawa S, Yoshio S, Yoshida Y, et al. Impact of Immune reconstitution-Induced hepatic flare on Hepatitis B Surface Antigen loss in Hepatitis B Virus\/Human Immunodeficiency Virus-1 coinfected patients. J Infect Dis Jun. 2021;15(12):2080\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiaa662.","journal-title":"J Infect Dis Jun"},{"issue":"5","key":"5681_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000002386","volume":"15","author":"J Audsley","year":"2020","unstructured":"Audsley J, Avihingsanon A, Littlejohn M, et al. Long-term TDF-Inclusive ART and progressive rates of HBsAg loss in HIV-HBV Coinfection-lessons for functional HBV cure? J Acquir Immune Defic Syndr. Aug. 2020;15(5):527\u201333. https:\/\/doi.org\/10.1097\/QAI.0000000000002386.","journal-title":"Aug"},{"issue":"5","key":"5681_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jhep.2016.10.002","volume":"66","author":"C Ferrari","year":"2017","unstructured":"Ferrari C, Boni C, Rossi M, et al. T cell regulation in HBV-related chronic liver disease. J Hepatol May. 2017;66(5):1096\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2016.10.002.","journal-title":"J Hepatol May"},{"issue":"5","key":"5681_CR11","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","volume":"1","author":"H Maier","year":"2007","unstructured":"Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8\u2009+\u2009T lymphocytes in the liver. J Immunol Mar. 2007;1(5):2714\u201320. https:\/\/doi.org\/10.4049\/jimmunol.178.5.2714.","journal-title":"J Immunol Mar"},{"issue":"6","key":"5681_CR12","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.23936","volume":"52","author":"B Raziorrouh","year":"2010","unstructured":"Raziorrouh B, Schraut W, Gerlach T, et al. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8\u2009+\u2009T-cell function. Hepatol Dec. 2010;52(6):1934\u201347. https:\/\/doi.org\/10.1002\/hep.23936.","journal-title":"Hepatol Dec"},{"issue":"6","key":"5681_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/apt.17306","volume":"57","author":"M Islam","year":"2023","unstructured":"Islam M, Sevak JK, Sharma MK, et al. Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. Aliment Pharmacol Ther Mar. 2023;57(6):689\u2013708. https:\/\/doi.org\/10.1111\/apt.17306.","journal-title":"Aliment Pharmacol Ther Mar"},{"issue":"1","key":"5681_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3350\/cmh.2021.0093","volume":"28","author":"SW Kim","year":"2022","unstructured":"Kim SW, Yoon JS, Lee M, Cho Y. Toward a complete cure for chronic hepatitis B: novel therapeutic targets for hepatitis B virus. Clin Mol Hepatol Jan. 2022;28(1):17\u201330. https:\/\/doi.org\/10.3350\/cmh.2021.0093.","journal-title":"Clin Mol Hepatol Jan"},{"key":"5681_CR15","doi-asserted-by":"publisher","first-page":"103464","DOI":"10.1016\/j.ebiom.2021.103464","volume":"69","author":"S Xiong","year":"2021","unstructured":"Xiong S, Zhu D, Liang B, et al. Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss. EBioMedicine Jul. 2021;69:103464. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103464.","journal-title":"EBioMedicine Jul"},{"issue":"2","key":"5681_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","volume":"73","author":"I Tout","year":"2020","unstructured":"Tout I, Loureiro D, Mansouri A, Soumelis V, Boyer N, Asselah T. Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development. J Hepatol Aug. 2020;73(2):409\u201322. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.013.","journal-title":"J Hepatol Aug"},{"issue":"15","key":"5681_CR17","doi-asserted-by":"publisher","first-page":"7649","DOI":"10.1128\/JVI.00183-09","volume":"83","author":"JJ Chang","year":"2009","unstructured":"Chang JJ, Sirivichayakul S, Avihingsanon A, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol Aug. 2009;83(15):7649\u201358. https:\/\/doi.org\/10.1128\/JVI.00183-09.","journal-title":"J Virol Aug"},{"key":"5681_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1743-422X-10-232","volume":"12","author":"X Zhang","year":"2013","unstructured":"Zhang X, Xing H, Feng X, Zhang H, Wang Y, Yan H. Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1). Virol J Jul. 2013;12:10:232. https:\/\/doi.org\/10.1186\/1743-422X-10-232.","journal-title":"Virol J Jul"},{"issue":"6","key":"5681_CR19","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1128\/JVI.02124-09","volume":"84","author":"M Crane","year":"2010","unstructured":"Crane M, Sirivichayakul S, Chang JJ, et al. No increase in hepatitis B virus (HBV)-specific CD8\u2009+\u2009T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy. J Virol Mar. 2010;84(6):2657\u201365. https:\/\/doi.org\/10.1128\/JVI.02124-09.","journal-title":"J Virol Mar"},{"issue":"7","key":"5681_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1086\/428502","volume":"1","author":"RM Lascar","year":"2005","unstructured":"Lascar RM, Lopes AR, Gilson RJ, et al. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis Apr. 2005;1(7):1169\u201379. https:\/\/doi.org\/10.1086\/428502.","journal-title":"J Infect Dis Apr"},{"issue":"12","key":"5681_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1086\/379896","volume":"15","author":"RM Lascar","year":"2003","unstructured":"Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus\/HBV coinfection. J Infect Dis Dec. 2003;15(12):1815\u20139. https:\/\/doi.org\/10.1086\/379896.","journal-title":"J Infect Dis Dec"},{"key":"5681_CR22","doi-asserted-by":"publisher","first-page":"1178788","DOI":"10.3389\/fcimb.2023.1178788","volume":"13","author":"X Li","year":"2023","unstructured":"Li X, Xu L, Lu L, et al. CD4(+) T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV\/HBV coinfection during combined antiretroviral therapy. Front Cell Infect Microbiol. 2023;13:1178788. https:\/\/doi.org\/10.3389\/fcimb.2023.1178788.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5681_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1186\/s12879-020-05675-3","volume":"10","author":"L Lin","year":"2020","unstructured":"Lin L, Yue YS, Wang ND, et al. Whole blood as an alternative to peripheral blood mononuclear cell for detection of total HIV-1 DNA. BMC Infect Dis Dec. 2020;10(1):941. https:\/\/doi.org\/10.1186\/s12879-020-05675-3.","journal-title":"BMC Infect Dis Dec"},{"issue":"3","key":"5681_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2018.05.004","volume":"69","author":"F Rinker","year":"2018","unstructured":"Rinker F, Zimmer CL, Honer Zu Siederdissen C, et al. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B. J Hepatol Sep. 2018;69(3):584\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.004.","journal-title":"J Hepatol Sep"},{"issue":"1","key":"5681_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1189\/jlb.0206118","volume":"80","author":"A Jabbari","year":"2006","unstructured":"Jabbari A, Harty JT. The generation and modulation of antigen-specific memory CD8 T cell responses. J Leukoc Biol Jul. 2006;80(1):16\u201323. https:\/\/doi.org\/10.1189\/jlb.0206118.","journal-title":"J Leukoc Biol Jul"},{"issue":"6","key":"5681_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1478-3231.2012.02764.x","volume":"32","author":"Z Huang","year":"2012","unstructured":"Huang Z, van Velkinburgh JC, Ni B, Wu Y. Pivotal roles of the interleukin-23\/T helper 17 cell axis in hepatitis B. Liver Int Jul. 2012;32(6):894\u2013901. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02764.x.","journal-title":"Liver Int Jul"},{"issue":"4","key":"5681_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/s0168-8278(03)00292-7","volume":"39","author":"C Boni","year":"2003","unstructured":"Boni C, Penna A, Bertoletti A, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol Oct. 2003;39(4):595\u2013605. https:\/\/doi.org\/10.1016\/s0168-8278(03)00292-7.","journal-title":"J Hepatol Oct"},{"issue":"6","key":"5681_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2893.2005.00716.x","volume":"13","author":"J Gotto","year":"2006","unstructured":"Gotto J, Webster GJ, Brown D, Jenkins J, Dusheiko GM, Bertoletti A. The impact of HBV-DNA fluctuations on virus-specific CD8\u2009+\u2009T cells in HBeAg\u2009+\u2009chronic hepatitis B patients treated with a steroid and lamivudine. J Viral Hepat Jun. 2006;13(6):415\u201325. https:\/\/doi.org\/10.1111\/j.1365-2893.2005.00716.x.","journal-title":"J Viral Hepat Jun"},{"issue":"5","key":"5681_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/135965350701200513","volume":"12","author":"GK Lau","year":"2007","unstructured":"Lau GK, Cooksley H, Ribeiro RM, et al. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. Antivir Ther. 2007;12(5):705\u201318.","journal-title":"Antivir Ther"},{"issue":"1","key":"5681_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hep.27805","volume":"62","author":"T Vanwolleghem","year":"2015","unstructured":"Vanwolleghem T, Hou J, van Oord G, et al. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells. Hepatol Jul. 2015;62(1):87\u2013100. https:\/\/doi.org\/10.1002\/hep.27805.","journal-title":"Hepatol Jul"},{"issue":"2","key":"5681_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jhep.2022.02.016","volume":"77","author":"NR Montanari","year":"2022","unstructured":"Montanari NR, Ramirez R, Aggarwal A, et al. Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. J Hepatol Aug. 2022;77(2):332\u201343. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.016.","journal-title":"J Hepatol Aug"},{"issue":"4","key":"5681_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","volume":"143","author":"C Boni","year":"2012","unstructured":"Boni C, Laccabue D, Lampertico P, et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology. 2012;143(4):963\u2013e739. https:\/\/doi.org\/10.1053\/j.gastro.2012.07.014.","journal-title":"Gastroenterology"},{"issue":"2","key":"5681_CR33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/HEP.0000000000000334","volume":"78","author":"Y Li","year":"2023","unstructured":"Li Y, Wen C, Gu S, et al. Differential response of HBV envelope-specific CD4\u2009+\u2009T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy. Hepatology. 2023;78(2):592\u2013606. https:\/\/doi.org\/10.1097\/HEP.0000000000000334.","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"5681_CR34","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","volume":"64","author":"A Bertoletti","year":"2016","unstructured":"Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol. 2016;64(1 Suppl):S71\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2016.01.026.","journal-title":"J Hepatol"},{"issue":"4","key":"5681_CR35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jhep.2022.12.013","volume":"78","author":"J Su","year":"2023","unstructured":"Su J, Brunner L, Ates Oz E, et al. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. J Hepatol. 2023;78(4):717\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2022.12.013.","journal-title":"J Hepatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05681-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05681-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T13:03:19Z","timestamp":1728046999000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05681-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5681"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05681-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki and approved by the Institutional Review Board of PUMCH. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"901"}}